REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 131 filers reported holding REVOLUTION MEDICINES INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,828,900 | +5.2% | 933,125 | +1.7% | 0.01% | 0.0% |
| Q2 2023 | $24,548,288 | +44.3% | 917,693 | +16.8% | 0.01% | +66.7% |
| Q1 2023 | $17,015,164 | +5.7% | 785,557 | +16.3% | 0.00% | 0.0% |
| Q4 2022 | $16,094,507 | +24.2% | 675,672 | +2.8% | 0.00% | 0.0% |
| Q3 2022 | $12,955,000 | +4.0% | 656,960 | +2.8% | 0.00% | 0.0% |
| Q2 2022 | $12,457,000 | -22.5% | 639,164 | +1.5% | 0.00% | 0.0% |
| Q1 2022 | $16,067,000 | +13.8% | 629,849 | +12.3% | 0.00% | +50.0% |
| Q4 2021 | $14,122,000 | -8.3% | 561,055 | +0.2% | 0.00% | -33.3% |
| Q3 2021 | $15,396,000 | -14.3% | 559,668 | -1.1% | 0.00% | 0.0% |
| Q2 2021 | $17,962,000 | -17.0% | 565,915 | +19.9% | 0.00% | -25.0% |
| Q1 2021 | $21,648,000 | +23.1% | 471,853 | +6.2% | 0.00% | +33.3% |
| Q4 2020 | $17,588,000 | +11.9% | 444,270 | -1.7% | 0.00% | 0.0% |
| Q3 2020 | $15,722,000 | +153.5% | 451,768 | +129.9% | 0.00% | +200.0% |
| Q2 2020 | $6,202,000 | +88.2% | 196,483 | +30.6% | 0.00% | 0.0% |
| Q1 2020 | $3,296,000 | – | 150,392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |